TEM Key Statistics, Chart & Performance
The current stock price of TEM is 57.12 USD. In the past month the price decreased by -13.81%. In the past year, price decreased by -36.14%.
TEM Technical Analysis
TEM Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TEM. While TEM seems to be doing ok healthwise, there are quite some concerns on its profitability.
TEM Financial Highlights
Over the last trailing twelve months TEM reported a non-GAAP Earnings per Share(EPS) of -0.75. The EPS increased by 85.75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.94% | ||
| ROE | -40.15% | ||
| Debt/Equity | 2.45 |
TEM Forecast & Estimates
19 analysts have analysed TEM and the average price target is 89.17 USD. This implies a price increase of 56.11% is expected in the next year compared to the current price of 57.12.
For the next year, analysts expect an EPS growth of 75.54% and a revenue growth 81.73% for TEM
TEM Ownership
TEM Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 22.03 | 203.947B | ||
| DHR | DANAHER CORP | 25.51 | 153.002B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 150.09 | 50.357B | ||
| A | AGILENT TECHNOLOGIES INC | 21.06 | 36.736B | ||
| IQV | IQVIA HOLDINGS INC | 14.73 | 31.929B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 29.87 | 28.062B | ||
| WAT | WATERS CORP | 22.68 | 22.698B | ||
| ILMN | ILLUMINA INC | 22.65 | 18.293B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.71 | 17.909B | ||
| MEDP | MEDPACE HOLDINGS INC | 31.55 | 15.269B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About TEM
Company Profile
Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. The company is headquartered in Chicago, Illinois and currently employs 2,400 full-time employees. The company went IPO on 2025-05-30. The company offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. The company provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Company Info
TEMPUS AI INC
600 West Chicago Avenue, Suite 510
Chicago ILLINOIS US
Employees: 2400
Phone: 18335144187
TEMPUS AI INC / TEM FAQ
What does TEM do?
Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. The company is headquartered in Chicago, Illinois and currently employs 2,400 full-time employees. The company went IPO on 2025-05-30. The company offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. The company provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Can you provide the latest stock price for TEMPUS AI INC?
The current stock price of TEM is 57.12 USD. The price increased by 4.02% in the last trading session.
Does TEM stock pay dividends?
TEM does not pay a dividend.
What is the ChartMill technical and fundamental rating of TEM stock?
TEM has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the analyst forecast for TEM stock?
19 analysts have analysed TEM and the average price target is 89.17 USD. This implies a price increase of 56.11% is expected in the next year compared to the current price of 57.12.
When does TEMPUS AI INC (TEM) report earnings?
TEMPUS AI INC (TEM) will report earnings on 2026-03-02.
Can you provide the ownership details for TEM stock?
You can find the ownership structure of TEMPUS AI INC (TEM) on the Ownership tab.